My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Surya Industrial Corporation to hold AGM

Surya Industrial Corporation to hold AGM

Sep 14,2016

Surya Industrial Corporation announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2016.

Powered by Capital Market - Live News

Jubilant Life gets healthier after receiving USFDA nod for drug
Apr 25,2017

The announcement was made during market hours today, 25 April 2017.

Meanwhile, the S&P BSE Sensex was up 185.93 points or 0.63% at 29,841.77.

On the BSE, 97,280 shares were traded on the counter so far as against the average daily volumes of 1.05 lakh shares in the past one quarter. The stock had hit a high of Rs 835.30 and a low of Rs 792.90 so far during the day.

The stock had hit a record high of Rs 879.10 on 12 April 2017 and a 52-week low of Rs 294.20 on 24 June 2016.

It had outperformed the market over the past one month till 24 April 2017, gaining 1.07% compared with the Sensexs 0.8% rise. The scrip had also outperformed the market over the past one quarter, advancing 13.83% as against the Sensexs 8.33% rise.

The large-cap company has equity capital of Rs 15.93 crore. Face value per share is Rs 1.

Jubilant Life Sciences announced that it has received Abbreviated New Drug Application (ANDA) final approval for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg from the United States Food & Drug Administration (USFDA).

Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg is the generic version of Benicar of Daiichi Sankyo, which is used for the treatment of hypertension.

This is the second approval that the company has received from the USFDA during the current financial year. The company had a total of 73 ANDAs for oral solids filed in the US, of which 49 have been approved.

Jubilant Life Sciences consolidated net profit fell 2.6% to Rs 119.78 crore on 8.7% rise in net sales to Rs 1438.81 crore in Q3 December 2016 over Q3 December 2015.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients and drug discovery solutions. The pharmaceuticals segment, through its wholly owned subsidiary Jubilant Pharma, is engaged in manufacture and supply of APIs, solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile and non-sterile products through 6 USFDA approved manufacturing facilities in India, USA and Canada.

The life science ingredients segment, is engaged in specialty intermediates, nutritional products and life science chemicals through 5 manufacturing facilities in India. The drug discovery solutions segment, provides proprietary in-house innovation & collaborative research and partnership for out-licensing through 3 world class research centres in India and USA.

Powered by Capital Market - Live News

Lupin allots 58569 equity shares
Apr 25,2017

Lupin has allotted 58569 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercising of options granted to the employees under Stock option plans of the Company. In view of the above, the issued and paid up capital of the Company has been increased to Rs. 90,32,70,876 consisting 45,16,35,438 equity shares of Rs. 2/- each.

Powered by Capital Market - Live News

Board of Northlink Fiscal and Capital Services accepts resignation of company secretary
Apr 25,2017

Northlink Fiscal and Capital Services informs the stock exchange that the Board of Directors at their meeting held on 24 April 2017 has approved the resignation of Sahil Khurana, Company Secretary of the company w.e.f. 31 March 2017.

Powered by Capital Market - Live News

FICCI urges the Government to finalise and announce the Tourism Policy this year itself
Apr 25,2017

FICCI (Federation of Indian Chambers of Commerce and Industry) has recommended to the Ministry of Tourism, Government of India, the announcement of National Tourism Policy in the year 2017. It is to be recalled that the draft of the policy had already been prepared in 2015 and had been distributed to the stakeholders for their inputs.

The report states that the draft policy reflects the evolving paradigm of the industry and has also suggested several developmental initiatives. FICCI has urged that the draft be finalized as a time-bound mission so that the policy can be released this year itself. The Policy will provide right impetus and direction to the state tourism policies as well. Furthermore, it will also ensure fast pace implementation of several key initiatives and institutional reforms proposed in the Draft Tourism Policy.

The other recommendations in the report relating to policy and regulatory interventions pertain to setting up of a National Tourism Authority, increasing budget allocation to tourism industry, suggesting lower GST slabs for tourism sector and increasing application window for e-visa from 1 month to 6 months. It also urges for promoting hassle free travel by increasing e-visas to more countries.

Snapshot of key statistics indicate that there is a rising trend of Tourism in India. India has also jumped 12 positions and stands at the 40th rank in Tourism & Travel competitive index, 2017 now. World Travel and Tourism Council (WTTC) research forecasts that between 2016 and 2026, the 10 fastest growing destinations for leisure-travel spending will be India. The shifts suggest that developing and emerging countries are catching up by providing better conditions to develop their Travel and Tourism competitiveness and, therefore, becoming better prepared to attract and welcome the millions of new tourists who will travel for the first time in the coming decade.

Tourisms contribution to capital investment is projected to grow 6.3 % p.a. during 2016-26, higher than the global average of 4.5%.

Contribution of visitor exports to total exports is estimated to increase 7.2 % p.a. during 2016-2026 compared to the world average of 4.3% pa. By 2025, Foreign Tourist Arrivals in India are expected to reach 15.3 million, according to the WTO.

Foreign Exchange Earnings (FEE) during the period January- February 2017 were Rs 31,357 crore with a growth of 14.9%, as compared to the foreign exchange earnings of Rs 27,296 crore with a growth of 15.0% in January-February 2016 over January-February 2015.

India ranked 3rd among 184 countries in terms of travel and tourisms total contribution to GDP in 2016. The sectors direct contribution to GDP is expected to grow by 8.6% p.a. during 2016-20.

Employment Generation within Indian tourism sector estimated to support 38.4 million jobs by 2016 which have been further forecasted to reach approx 46 million jobs by 2026.

Domestic travel spending generated 82.5% of direct Travel & Tourism GDP in 2015 compared with 17.5% for visitor exports. Domestic travel spending is expected to rise by 7.8% pa to Rs 13,305.5bn in 2026 while visitor exports are expected to rise by 7.2% pa to Rs 2,625.6 bn in 2026.

Powered by Capital Market - Live News

Wendt (India) advances after good Q4 earnings
Apr 25,2017

The result was announced after market hours yesterday, 24 April 2017.

Meanwhile, the S&P BSE Sensex was up 190.47 points or 0.64% at 29,846.71.

On the BSE, 526 shares were traded on the counter so far as against the average daily volumes of 481 shares in the past two weeks. The stock had hit a high of Rs 2,360 and a low of Rs 2,300 so far during the day. The stock had hit a 52-week high of Rs 2,445 on 21 April 2017 and a 52-week low of Rs 1,666 on 26 December 2016.

Wendt (India)s board recommended a dividend of Rs 15 per share for the year ended March 2017.

Wendt (India) is a manufacturer of super abrasives, grinding, honing and special purpose machines and components.

Powered by Capital Market - Live News

IndusInd Bank nudges higher after opening new branch
Apr 25,2017

The announcement was made after market hours yesterday, 24 April 2017.

Meanwhile, the S&P BSE Sensex was up 191.31 points, or 0.65% to 29,847.15.

On the BSE, 3,721 shares were traded in the counter so far, compared with average daily volumes of 1.44 lakh shares in the past one quarter.

The stock had hit a high of Rs 1,444 and a low of Rs 1,435.20 so far during the day. The stock had hit a record high of Rs 1,444.55 on 13 April 2017. The stock had hit a 52-week low of Rs 965.65 on 21 April 2016.

It had outperformed the market over the past one month till 24 April 2017, gaining 3.19% compared with the Sensexs 0.8% rise. The scrip had also outperformed the market over the past one quarter, advancing 14.56% as against the Sensexs 8.33% rise.

The large-cap private sector bank has equity capital of Rs 598.21 crore. Face value per share is Rs 10.

Expanding presence across Jharkhand, IndusInd Bank recently inaugurated its third branch in Jamshedpur, the first planned industrial city of India. The branch is located at Mango, Jamshedpur.

With the inauguration of this branch, the bank now has 19 branches in Jharkhand.

Meanwhile, IndusInd Bank announced during market hours yesterday, 24 April 2017 that it recently inaugurated its first branch in Bhinder, known for its silver and cloth market. The branch is located at Rampole Darwaja, station road, Bhinder, Udaipur, Rajasthan. With the inauguration of this branch, the bank now has 94 branches in Rajasthan.

IndusInd Banks net profit rose 21.2% to Rs 751.61 crore on 22.4% increase in total income to Rs 5041.31 crore in Q4 March 2017 over Q4 March 2016.

Induslnd Bank is a private sector bank and caters to the needs of both consumer and corporate customers.

Powered by Capital Market - Live News

ADB Lending Hits Record High in its 50th Year as Infrastructure Demand Rises
Apr 25,2017

The Asian Development Banks (ADB) annual operations exceeded the $30 billion mark for the first time in its 50-year history last year as regional demand for development finance and knowledge n++ particularly on infrastructure n++ continues to grow, according to the banks 2016 Annual Report (AR) released today.

ADBs total lending in 2016, including co-financing, reached $31.70 billion n++ an 18% increase from 2015, according to the annual report. The total include $17.47 billion in approvals for loans and grants, $169 million for technical assistance, and $14.06 billion for co-financing, which increased by a record 31% over 2015. Disbursements, a key indicator for successful project implementation, also reached a new high of $12.26 billion in 2016.

Private sector operations reached $2.5 billion for only the second time in ADBs history n++ a result reflecting ADBs long-term strategy to significantly boost support for private enterprise to create more high quality jobs and increase living standards across Asia and the Pacific. Apart from its own funds, ADBs private sector operations also generated a record $5.84 billion in co-financing n++ a $1.2 billion increase from 2015 n++ which included $238 million in official co-financing to support non-sovereign operations.

These figures update the provisional operations numbers released by ADB in January.

n++The increase in our development financing to Asia and the Pacific reflects our strong commitment to improving the lives of the people in the region,n++ said ADB President Takehiko Nakao. n++As ADB celebrates 50 years of providing development assistance, we will strive even harder to meet the changing needs of our developing member countries.n++

The 2016 AR reviews the significant economic transformation in Asia and the Pacific over the past 50 years, and the role played by ADB to support the regions development to improve peoples lives. The report notes that while the regions economic growth and success in reducing poverty have exceeded the most optimistic forecasts, there remain significant challenges to be addressed.

n++We cannot be complacent,n++ said President Nakao. n++The fact remains there are still 330 million people living in absolute poverty across Asia and the Pacific. A lack of infrastructure continues to limit economic growth, inhibit poverty reduction, and restrict improvements to quality of life.n++

ADB estimates that the region requires $1.7 trillion a year to meet its infrastructure financing needs. There are other pressing challenges such as climate change, health, education, and gender equality. To help address these development needs, ADB has scaled up its operations and expanded its financing capacity through the merger of its Asian Development Fund (ADF) lending operations with the Ordinary Capital Resources (OCR) balance sheet, which became effective on 1 January this year. OCR equity almost tripled, from $17.3 billion to $48.1 billion, as $30.8 billion of ADF loans and other assets were transferred from the ADF. The merger is expected to increase ADBs annual loan and grant approvals by over 50% to more than $20 billion by 2020.

ADB will also increase grant support to its poorest countries by 70% over the next 4 years, following the successful $3.3 billion replenishment of the ADF in May 2016. Contributions from 32 donors, including an increase in pledges from emerging Asian economies, will allow ADB to double the minimum allocation for small countries, provide strengthened support for disaster risk management, and offer greater assistance for regional health security.

Powered by Capital Market - Live News

Board of Rallis India recommends final dividend
Apr 25,2017

Rallis India announced that the Board of Directors of the Company at its meeting held on 24 April 2017, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 250%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Board of Tata Metaliks recommends final dividend
Apr 25,2017

Tata Metaliks announced that the Board of Directors of the Company at its meeting held on 21 April 2017, inter alia, have recommended the final dividend of Rs 2.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Wendt India to hold AGM
Apr 25,2017

Wendt India announced that the Annual General Meeting (AGM) of the company will be held on 24 July 2017.

Powered by Capital Market - Live News

Board of Reliance Industries recommends final dividend
Apr 25,2017

Reliance Industries announced that the Board of Directors of the Company at its meeting held on 24 April 2017, inter alia, have recommended the final dividend of Rs 11 per equity Share (i.e. 110%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Board of Wendt India recommends final dividend
Apr 25,2017

Wendt India announced that the Board of Directors of the Company at its meeting held on 24 April 2017, inter alia, have recommended the final dividend of Rs 15 per equity Share (i.e. 150%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Lumax declines on profit booking
Apr 25,2017

Meanwhile, the S&P BSE Sensex was up 179.86 points or 0.61% at 29,835.70. The S&P BSE Small-Cap index was up 117.01 points or 0.77% at 15,408.27.

On the BSE, 2,485 shares were traded on the counter so far as against the average daily volumes of 4,251 shares in the past one quarter. The stock had hit a high of Rs 1,540 and a low of Rs 1,481.15 so far during the day.

The stock had hit a record high of Rs 1,561.55 on 24 April 2017 and a 52-week low of Rs 430.50 on 4 May 2016. It had outperformed the market over the past one month till 24 April 2017, surging 11.82% compared with the Sensexs 0.8% rise. The scrip had also outperformed the market over the past one quarter, gaining 38.1% as against the Sensexs 8.33% rise.

Shares of Lumax Industries had rallied 12.2% to settle at Rs 1,522.65 in a single trading session yesterday, 24 April 2017, after the company said after market hours on 21 April 2017 that it has received a new customer order.

Lumax Industries said it has received order to supply new age headlamps and rear lamps for the new generation Maruti Suzuki Swift that commences production later this year at carmakers Gujarat facility in Mehsana district. The order will be fulfilled from the Sanand plant.

Lumax has done a capex of about Rs 120 crore, at Sanand, which is expected to commence operations from November 2017. The capex has been funded through internal accruals.

Going forward, the plant is expected to cater to the needs of TATA Tigor at Sanand as well as HMSIs existing models at Gujarat. The facility will have a capacity of about 3 lakh car-sets annually. The plant is expected to be operational at its full capacity by FY19-20.

On consolidated basis, Lumax Industries net profit rose 67.7% to Rs 17.04 crore on 3.4% decline in net sales to Rs 297.15 crore in Q3 December 2016 over Q3 December 2015.

Lumax Industries is one the leading players in the automotive lighting industry in India.

Powered by Capital Market - Live News

Alembic Pharmaceuticals receives final approval for Olmesartan Medoxomil Tablets & Medoxomil with Hydrochlorothiazide Tablets
Apr 25,2017

Alembic Pharmaceuticals has received USFDA final approval for Olmesartan Medoxomil Tablets, 5mg, 20mg and 40mg and Olmesartan Medoxomil with Hydrochlorothiazide Tablets 20/12.5 mg, 40/12.5 mg and 40/25 mg. The approved ANDAs are indicated for the treatment of hypertension.

Powered by Capital Market - Live News

Jubilant Life Sciences receives final approval for Olmesartan Medoxomil Tablets
Apr 25,2017

Jubilant Life Sciences has received from USFDA Abbreviated New Drug Application final approval for Olmesartan Medoxomil Tablets, 5 mg, 20 mg and 40 mg, the generic version of Benicar of Daiichi Sankyo, which is used for the treatment of hypertension.

Powered by Capital Market - Live News